Fetal bradycardia and vasa previa in a pregnant woman with insulin resistance: A case report

Bradicardia fetal y vasa previa en gestante con resistencia a la insulina: Reporte de caso

Authors

  • Alvaro Leonardo Beltrán-Vidal Universidad del Azuay (UDA). Cuenca, Ecuador.
  • Daniela de la Nube Pacheco-Galindo Universidad del Azuay (UDA). Cuenca, Ecuador.
  • Elsa Alicia Landi-Faican Universidad de Cuenca. Cuenca, Ecuador.
  • Lorena Estefania Vintimilla-Martinez Universidad del Azuay (UDA). Cuenca, Ecuador.
  • Sofía Bernarda Ortiz-Álvarez Clínica de Especialidades ALELI. Cuenca, Ecuador. https://orcid.org/0009-0003-2071-5687

DOI:

https://doi.org/10.22258/hgh.v10i2.407

Abstract

Introduction: Vasa previa is a rare but potentially catastrophic obstetric condition characterized by the presence of fetal vessels running through the fetal membranes without the protection of Wharton's jelly. Timely prenatal diagnosis significantly reduces perinatal mortality; however, atypical presentations may occur. Case report: We report the case of a 26-year-old primigravida with a history of insulin resistance and Class I obesity, who presented at 28.3 weeks of gestation with severe fetal bradycardia in the absence of vaginal bleeding. Monitoring revealed a non-reassuring fetal heart rate pattern with decelerations reaching 83 bpm. Betamethasone was administered for fetal lung maturity and magnesium sulfate for neuroprotection. Due to persistent fetal compromise, an emergency cesarean section was performed. Intraoperatively, a velamentous cord insertion was identified with exposed fetal vessels consistent with vasa previa and a peri-insertional hematoma. A preterm newborn weighing 1200 g was obtained, with an Apgar score of 8 and 9 at the first and fifth minute, respectively. Maternal recovery was favorable. Conclusions: Isolated fetal bradycardia can be a sentinel manifestation of vasa previa, even without bleeding. A high index of suspicion and timely obstetric intervention are fundamental to improving perinatal outcomes. Keywords: Vasa Previa; Cesarean Section; Pregnancy, High-Risk (Source: MeSH, NLM).

Downloads

Download data is not yet available.

Author Biographies

Alvaro Leonardo Beltrán-Vidal , Universidad del Azuay (UDA). Cuenca, Ecuador.

Médico Especialista en Ginecología y obstetricia. Magister en Sexología y terapia de pareja. Experto universitario en cribado de cáncer de Cérvix.

Daniela de la Nube Pacheco-Galindo, Universidad del Azuay (UDA). Cuenca, Ecuador.

Postgrado en Docencia Universitaria, Posgradista en Ginecología y Obstetricia. Universidad del Azuay (UDA). Cuenca, Ecuador.

Elsa Alicia Landi-Faican , Universidad de Cuenca. Cuenca, Ecuador.

Posgradista en Ginecología y Obstetricia. Universidad de Cuenca. Cuenca, Ecuador.

Lorena Estefania Vintimilla-Martinez, Universidad del Azuay (UDA). Cuenca, Ecuador.

Posgradista en Ginecología y Obstetricia. Universidad del Azuay (UDA). Cuenca, Ecuador.

Sofía Bernarda Ortiz-Álvarez , Clínica de Especialidades ALELI. Cuenca, Ecuador.

Médico General, Clínica de Especialidades ALELI. Cuenca, Ecuador.

References

Zhang W, Geris S, Beta J, Ramadan G, Nicolaides KH, Akolekar R. Prevention of stillbirth: impact of two-stage screening for vasa previa. Ultrasound Obstet Gynecol 2020;55:605–612. DOI: 10.1002/uog.21953.

Ruano R, Mihulka O, Hombal A, Ravelo N, Slesnick L, Pierucci UM. Fetoscopic laser ablation of type II Vasa previa-case report and systematic review. Prenat Diagn 2025;45:1660–1666. DOI: 10.1002/pd.6897.

Oyelese Y, Javinani A, Gudanowski B, Krispin E, Rebarber A, Akolekar R, et al. Vasa previa in singleton pregnancies: diagnosis and clinical management based on an international expert consensus. Am J Obstet Gynecol 2024;231(6):638.e1-638.e24. DOI: 10.1016/j.ajog.2024.03.013.

Conyers S, Oyelese Y, Javinani A, Jamali M, Zargarzadeh N, Akolekar R, et al. Incidence and causes of perinatal death in prenatally diagnosed vasa previa: a systematic review and meta-analysis. Am J Obstet Gynecol 2024;230(1):58–65. DOI: 10.1016/j.ajog.2023.06.015.

Wang MJ, Duffy CR, Oyelese Y. Case report of recurrent vasa previa. Australas J Ultrasound Med 2025;28(1):e12405. DOI: 10.1002/ajum.12405.

Pozzoni M, Sammaria C, Villanacci R, Borgese C, Ghisleri F, Farina A, et al. Prenatal diagnosis and postnatal outcome of Type-III vasa previa: systematic review of literature. Ultrasound Obstet Gynecol 2024;63:24–33. DOI: 10.1002/uog.26315.

Case study investigation. American Academy of Audiology 2017. https://www.audiology.org/news-and-publications/audiology-today/articles/case-study-investigation-considering-birth-history-when-it-comes-to-high-frequency-hearing/ (consultado el 1 de marzo de 2026).

Zhang W, Geris S, Al-Emara N, Ramadan G, Sotiriadis A, Akolekar R. Perinatal outcome of pregnancies with prenatal diagnosis of vasa previa: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2021;57:710–719. DOI: 10.1002/uog.22166.

José Canto Rivera M, Bachs SC, Vilarmau MG, Capdevila JP, Pérez FO. Vasa previa: diagnóstico prenatal ecográfico y conducta obstétrica. Prog Obstet Ginecol 2009;52 (11):643–647. DOI: 10.1016/s0304-5013(09)72802-x.

Ferrero Viñas A, Cortejoso Hernández J, de Miguel Manso S, Suárez Mansilla P, Álvarez Colomo C, González Martín JI. Vasa previa, diagnóstico prenatal y manejo obstétrico. Clin Invest Ginecol Obstet 2020;47(1):18–21. DOI: 10.1016/j.gine.2019.06.002.

Jain V, Gagnon R. Guideline No. 439: Diagnosis and management of Vasa previa. J Obstet Gynaecol Can 2023;45(7):506–18. DOI: 10.1016/j.jogc.2023.05.009.

Jauniaux E, Alfirevic Z, Bhide AG, Burton GJ, Collins SL, Silver R, et al. Vasa praevia: Diagnosis and management. Green-top guideline No. 27b. BJOG 2019;126:e49–61. DOI: 10.1111/1471-0528.15307.

Kanda E, Matsuda Y, Kamitomo M, Maeda T, Mihara K, Hatae M. Prenatal diagnosis and management of vasa previa: a 6-year review: Prenatal diagnosis of vasa previa. J Obstet Gynaecol Res 2011;37:1391–1396. DOI: 10.1111/j.1447-0756.2011.01544.x.

Laiu S, McMahon C, Rolnik DL. Inpatient versus outpatient management of prenatally diagnosed vasa praevia: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 2024;293:156–166. DOI: 10.1016/j.ejogrb.2023.11.033.

Lueck T, Macharia A, Modest A, Shainker SA, Kleeman L, Agudogo S, et al. Vasa previa screening, diagnosis, management and outcomes: single-center study. Ultrasound Obstet Gynecol 2025;66:194–199. DOI: 10.1002/uog.29268.

Roberts DJ, Torous V. Placental pathology. Reproductive and Developmental Toxicology, Elsevier; 2022, p. 1399–1420. DOI: 10.1016/B978-0-323-89773-0.00069-2

Published

2026-06-15

How to Cite

Beltrán-Vidal , A. L., Pacheco-Galindo, D. de la N., Landi-Faican , E. A., Vintimilla-Martinez, L. E., & Ortiz-Álvarez , S. B. (2026). Fetal bradycardia and vasa previa in a pregnant woman with insulin resistance: A case report: Bradicardia fetal y vasa previa en gestante con resistencia a la insulina: Reporte de caso . Peruvian Journal of Health Care and Global Health, 10(2). https://doi.org/10.22258/hgh.v10i2.407

Issue

Section

Case reports

Most read articles by the same author(s)